Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

RSS icon

HHS Secretary defends eliminating required health benefits

In an interview with CNN, HHS Secretary Tom Price, MD, continued to defend Republican alternatives to the Affordable Care Act (ACA), calling the American Health Care Act (AHCA) “a significantly better program than the one we currently have.”

NCCN Survey Reveals Oncology's Concerns about Financial Distress, Patient Access to Care

Oncology community professionals are concerned about the ability of their patients to access cancer screening and treatment under the proposed American Health Care Act, according to a survey conducted March 23–24, 2017 at the National Comprehensive Cancer Network® (NCCN®) 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ at the Rosen Shingle Creek in Orlando, Florida.

CMS Administrator doesn’t ease insurers’ concerns on subsidies

Insurance companies that are members of America’s Health Insurance Plans (AHIP) made their case to CMS for billions in cost-sharing reduction subsidies under the Affordable Care Act to continue—but left with no promises the administration would maintain funding.

EMS Professionals Will Appeal to Congress to Support Life-saving Services and Patient Access to Emergency Medications at EMS On The Hill Day

Hundreds of emergency and mobile healthcare professionals, representing emergency medical services (EMS) in almost every U.S. state, will assemble on Capitol Hill to request support from congressional leaders on issues vital to the health and safety of every community in our nation.

Insurers still jittery about ACA market after CMS rule

The final rule aimed at stabilizing the Affordable Care Act’s health insurance exchanges doesn’t appear to have won the perception battle with insurers debating whether to participate in the marketplace.

South Carolina hospitals check off 'reduce post-surgical deaths' with safety checklist

Having a checklist for chores or exercise goals help in lining up what needs to be completed and the same should go for safety in hospitals. A recent study, set to be published in August in the Annals of Surgery, found that having a safety checklist program implemented in hospitals in South Carolina reduced post-surgical deaths by 22 percent. 

Thumbnail

Hospitals give mixed reaction to IPPS proposed rule despite $3.1B boost

CMS released the 2018 Medicare Inpatient Prospective Payment System (IPPS) proposed rule on April 14, promising “transparency, flexibility, program simplification and innovation to transform the Medicare program” in the first IPPS rule under a new CMS and HHS administration.

HHS Secretary wants physicians’ ideas for new payment models

HHS Secretary Tom Price, MD, is encouraging physicians to submit more suggestions on new Medicare payment models to move away from fee-for-service payments.

Displaying 2017 - 2024 of 2773

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup